"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila
TOKYO, July 30 /PRNewswire/ -- With a business plan to launch 8-10 new
products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of
the Zydus group, one of India's leading integrated pharma companies & a
global healthcare provider, is looking to give a big boost to its ope...
Oprah, Luke Skywalker and Maradona -- new study investigates how our brains respond to them
Pictures paint concepts of a thousand words- now, for the first time, scientists studying the brain have worked out how words paint concepts in our
The team, including Professor Rodrigo Quian Quiroga at the Department of Engineering of the University of Leicester in the UK, Professor Itz...
Use it or lose it? Researchers investigate the dispensability of our DNA
October 2, 2008 Our
genome contains many genes encoding proteins that are similar to those of other organisms, suggesting evolutionary relationships; however, protein-coding genes account for only a small fraction the genome, and there are many other DNA sequences that are conserved across specie...
Scientists fix bugs in our understanding of evolution
What makes a human different from a chimp? Researchers from the European Molecular Biology Laboratory's European Bioinformatics Institute [EMBL-EBI] have come one important step closer to answering such evolutionary questions correctly. In the current issue of Science they uncover systematic err...
Humour is Fundamental to our Success as a Species
First Universal Theory of Humour Answers how and why we Find Things Funny
CARLISLE, England, June 13 /PRNewswire/ -- Published today The Pattern
Recognition Theory of Humour, by Alastair Clarke, answers the eternal
question of what is humour. Clarke explains how and why we find things
Serving Those Who Serve Our Country: Medical Device Company Answers the Call of a U.S. Combat Hospital in Iraq
NASHUA, N.H., May 13 /PRNewswire/ -- When Sergeant Heather Maddy of the
325th Combat Support Hospital in Iraq e-mailed Vascular Technology,
Incorporated (VTI) of Nashua, NH inquiring about a desperately needed piece
of critical care equipment called a Surgical Doppler for her operating
Commentary: Is our Biosphere too cheesy?
A great perk to traveling getting to see what the rest of the world is doing. Last week I was in Phoenix vacationing with the family for spring break, content to play a few rounds of golf and see a ballgame, when I was confronted with a barrage of hype over Arizonas biotech efforts. While I manage...
Maybe its time to write our own television shows about Wisconsin
MADISON, WI With the Fox Network ready to air a sitcom set in mythical Waterford Falls, Wis., the Badger state will once again bask in prime-time televisions limelight whether it wants to or not.
Consider yourself warned: A Minute with Stan Hooper, which stars Norm Macdonald of Saturday Night L...
Technology Helps Our Economy to Survive and Grow
In the last 24 months, many Wisconsin businesses have had to find new ways to compete. They discovered that previous paths to success no longer worked and most CEOs have taken a hard look at their companys value proposition. At the same time, these companies are attempting to be more effective, pro...
What If We Cut Our Own Path?
What if we didnt spend so much time trying to be the next Silicon Valley? I have lived in both places, and if Wisconsins technology roadmap is to become a Midwest carbon copy of Silicon Valley, we should save ourselves the frustration. The cultural differences in business, labor and general popul...
In our changing economy, just-in-time employment masks job creation numbers
MADISON Maybe its not a jobless recovery, after all. Perhaps its just a matter of how we count 21st century jobs.
U.S. Labor Department figures for March showed the addition of 308,000 jobs to the economy, which is double what it takes (150,000 jobs) in an average month to keep pace with growth...
Ethanol bill's death in Wisconsin ignores what's happening with our neighbors
In the same week that state senators in Wisconsin killed a bill to require gasoline in the state to include ethanol, policymakers in another Midwestern state were celebrating their latest step toward a more bio-based economy.
Agri-business giant Louis Dreyfus Corp. announced it will build the...
Re-engineering our economy to be sustainable and profitable
Madison, Wis. - If you dropped the word sustainability in a crowd of business executives five years ago, most of them would have pegged you as an aging hippie, then scrambled away to avoid any lectures about riding their bikes to work.
Today, sustainability still carries some linguistic bagg...
Fueling our economy with the University of Wisconsin
M adison, Wis. - For the first time in the team's history, the University of Wisconsin men's basketball team recently was ranked first in the nation, giving Wisconsin fans just one more reason to be proud. March Madness is just around the corner, and I know the team will enjoy tremendous su...
Changes to U.S. patent law must nurture our culture of innovation
Madison, Wis. - Be very afraid when a member of Congress announces that a major reason to reform the U.S. patent system is that no one else in the world does it like us.
Even during an era when America-bashing is back in vogue, there are certain things this country does well - and has always...
DOE awards $377 million in funding for 46 energy frontier research centers
...gy demand grows, there is an urgent need to reduce our
dependence on imported oil and curtail greenhouse ...d Secretary Chu. "Meeting the challenge to reduce our
dependence on imported oil and curtail greenhouse ...s will mobilize the enormous talents and skills of our
nation's scientific workforce in pursuit of the br...
...reported these results in the journal Science. "In our
study, we found that coalescence events are freque...ll sample.
"The JEOL 3010 In-Situ Microscope is our
best machine for imaging dynamic events, and at 30...hesis for tailored properties," says Zheng. "Also, our
in situ liquid cell TEM technique can be applied t...
Schering-Plough Shareholders Approve Merger With Merck
...t of common shares voting.
"Today's vote by our
shareholders reflects the potential they see to cr...nd CEO. "After six years of transformation under our
Action Agenda, our
Schering-Plough colleagues can be very proud of th...
SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...iscussions with a number of potential partners for our
12-hour controlled release ibuprofen. These potent...nd international markets. We continue to work with our
investment bankers on potential strategic transact...and provide additional resources for us to develop our
Controlled Delivery Technology (CDT(R)) platforms....
Novavax Reports Second Quarter 2009 Financial Results
...luding a facility for the Spanish government using our
proprietary, recombinant VLP vaccine technology. ...fficer, Dr. Rahul Singhvi. "We eliminated 100% of our
$22 million outstanding convertible debt and raise...illion through the sale of additional shares under our
ATM program. Today, Novavax has a healthy balance...
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
...oFit bone void filler is an important component of our
future cartilage repair business," commented Joe K...espect to the development and commercialization of our
Cartilage Repair Device," he concluded.
The...pport regulatory approval of future generations of our
products and competition from other technologies. ...
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
... cash to complete the analysis of the results from our
cocaine trial and methamphetamine study and to continue our
operations through the end of 2010 without additio...talyst's Chief Executive Officer. "We believe that our
financial and human resources are sufficient to pu...
NeurogesX Reports Second Quarter 2009 Results
...nd CEO, commented, "The second quarter of 2009 was our
most significant three-month period to date. With ...ion of Qutenza in Europe we significantly advanced our
progression into a commercial company while finalizing our
partnership with Astellas fulfilled an important p...
AOBO Announces New Product Launch
...very pleased to be launching the Jingwei
Capsule, which is complementary to our
market-leading Boke nasal spray. Its
major competitor is Schering-Plough's.... We are confident in our
future growth prospects as we continue to expand our
product lines and launch
innovative new products."
About American O...
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
...rves. At the same time, it enables Viral Genetics to remain focused on its core mission of pursuing treatments for autoimmune diseases, in addition to our
primary focus of HIV and AIDS."
Viral Genetics has an option to acquire exclusive rights to the metabolic disruption technology from the Unive...
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
Bioengineering, commented, "We are pleased with our
second quarter performance
as we continued to enhance our
diversified product portfolio and pursue
further vertical integration. our
marketing capabilities, extensive
Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
...x will have the right to redeem the notes in whole or in part at a specified redemption price on or after August 20, 2013 if the last reported sale of our
common stock exceeds 130% of the conversion price then in effect for 20 or more trading days in a period of 30 consecutive trading days ending on the ...
AutoImmune Inc. Reports 2009 Second Quarter Financial Results
...s in the first six months of 2009 at Colloral LLC, our
joint venture with Deseret Laboratories, Inc., mor... period in 2008. The response to marketing through our
licensee, Bronson Laboratories, LLC remains encour...se forward-looking statements because they involve our
expectations, beliefs, projections, anticipations ...
ThermoGenesis Announces Expanded Collaboration With Celling Technologies
...udy results will accelerate the market adoption of our
bone marrow processing technologies and should inc...g of FDA approvals, changes in customer forecasts, our
failure to meet customers' purchase order and qual...s' products, introduction timing and acceptance of our
new products scheduled for fiscal years 2009 and 2...
Synthetech Reports First Quarter Fiscal 2010 Results
...come of $969,000 further exemplify the benefits of our
actions aimed at expanding markets, improving prod...pportunities, and better than expected strength in our
biopharmaceutical customer base. In addition, the full benefit of our
cost reduction plan implemented in the first quart...
Microbix Sales Grow 22% For Nine Months
...9 is a trend we expect to continue in fiscal 2010. our
new manufacturing facility is fully operational, c...biological markets that have the potential to grow our
opportunity base significantly over our
Influenza Vaccine Busin...
GenVec Reports Second Quarter 2009 Financial Results
... experienced decreases in revenues associated with our
FMD and malaria programs, partially offset by increased revenue associated with our
HIV program, as compared to the comparable prior y...arch 2009. The increase in revenue associated with our
HIV program in each period is due mainly to increa...
Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
...are pleased to welcome Fred Driscoll to Novavax as our
new chief financial officer. Fred is joining Nova...a critical juncture will be welcome by everyone on our
Executive Team. We are looking forward to tappin... of biotechnology industry experience as we expand our
vaccine development programs, manufacturing operat...
Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
...innovative technologies and efficient solutions to our
global pharmaceutical and biotechnology customers,... leading Life Science and High Technology company. our
chemical and biochemical products and kits are use... Over one million scientists and technologists use our
products. Sigma-Aldrich operates in 38 countries a...
ThermoGenesis Provides Update on Fiscal 2009 Results
...ortion of the non-recurring charges are related to our
AXP quality initiative, which is a major focus for... manufacturing activities and implement changes to our
structure to ensure we are properly focused on our
Engle said the following fa...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
...have made excellent progress on the preparation of our
New Drug Application (NDA) for pirfenidone which w...for potential approval in the first review cycle. our
Marketing Authorization Application (MAA) is also ... and monkeys, respectively which clear the way for our
Phase 2 and Phase 3 clinical programs;...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
... period has been a challenging time for SEQUENOM. our
announcement at the end of April was immensely disappointing and has resulted in a setback in our
molecular diagnostics programs. However, I believe...and CEO of SEQUENOM. "We have made improvements to our
MassARRAY platform and we are poised to introduce ...
OncoGenex Reports Second Quarter 2009 Financial Results
... months of 2009 associated with the development of our
product candidates OGX-011 and OGX-427, an increas... 2009,
which leaves us well positioned to focus on our
primary objective to secure a
co-development and commercialization partner for our
OGX-011 program," said
Scott Cormack, President an...
Telik Announces Second Quarter 2009 Financial Results
...nses were approximately 43% lower in the second quarter of 2009 compared with the same period in 2008, primarily due to lower headcount as a result of our
restructuring in February 2009, reduced research, clinical trial and related expenses and lower stock compensation expense.
For the six months ...
Ratcliff Adds Architect John Sealander to Healthcare Practice Group
...from 2004-2006 and now chairs again.
"I am impressed with the depth of planning, programming and design experience the Ratcliff team possesses. our
firm is just the right size to undertake any healthcare project, from major new hospital construction to modest renovations," said Sealander, who supp...